Screening of Common Herbal Medicines as Promising Direct Inhibitors of Sars-Cov-2 in Silico

References (45)

1. 1 UCSF Chimera—A visualization system for exploratory research and analysis [DOI]
2. 2 A pneumonia outbreak associated with a new coronavirus of probable bat origin [DOI]
3. 3 The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China [DOI]
4. 4 Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission [DOI]
5. 5 SwissDock, a protein-small molecule docking web service based on EADock DSS [DOI]
6. 6 Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease [DOI]
7. 7 Identification of natural compounds with antiviral activities against SARS-associated coronavirus [DOI]
8. 8 Specific Plant Terpenoids and Lignoids Possess Potent Antiviral Activities against Severe Acute Respiratory Syndrome Coronavirus [DOI]
9. 9 Small molecules targeting severe acute respiratory syndrome human coronavirus [DOI]
10. 10 Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography [DOI]
11. 11 Antiviral Activity of Glycyrrhizic Acid Derivatives against SARS−Coronavirus [DOI]
12. 12 An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study [DOI]
13. 13 High-Throughput Screening and Identification of Potent Broad-Spectrum Inhibitors of Coronaviruses [DOI]
14. 14 A novel network pharmacology approach to analyse traditional herbal formulae: the Liu-Wei-Di-Huang pill as a case study [DOI]
15. 15 Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases [DOI]
16. 16 Chalcones isolated fromAngelica keiskeiinhibit cysteine proteases of SARS-CoV [DOI]
17. 17 Quercetin inhibits rhinovirus replication in vitro and in vivo [DOI]
18. 18 SARS-CoV 3CLpro inhibitory effects of quinone-methide triterpenes from Tripterygium regelii [DOI]
19. 19 Dieckol, a SARS-CoV 3CLpro inhibitor, isolated from the edible brown algae Ecklonia cava [DOI]
20. 20 Randomised clinical trial to determine the safety of quercetin supplementation in patients with chronic obstructive pulmonary disease [DOI]
21. 21 Statistical evidence for the usefulness of Chinese medicine in the treatment of SARS [DOI]
22. 22 Virtual screening for finding natural inhibitor against cathepsin-L for SARS therapy [DOI]
23. 23 Papain-Like Protease (PLpro) Inhibitory Effects of Cinnamic Amides from Tribulus terrestris Fruits [DOI]
24. 24 Inhibitors of SARS-3CL pro : Virtual Screening, Biological Evaluation, and Molecular Dynamics Simulation Studies [DOI]
25. 25 Isolation of quinic acid derivatives and flavonoids from the aerial parts of Lactuca indica L. and their hepatoprotective activity in vitro [DOI]
26. 26 A novel systems pharmacology model for herbal medicine injection: a case using reduning injection [DOI]
27. 27 Brain-inspired cheminformatics of drug-target brain interactome, synthesis, and assay of TVP1022 derivatives [DOI]
28. 28 ANN Multiscale Model of Anti-HIV Drugs Activity vs AIDS Prevalence in the US at County Level Based on Information Indices of Molecular Graphs and Social Networks [DOI]
29. 29 Quinic acid derivatives inhibit dengue virus replication in vitro [DOI]
30. 30 SARS‐CoV protease inhibitors design using virtual screening method from natural products libraries [DOI]
31. 31 Structure Identification and Anti-Cancer Pharmacological Prediction of Triterpenes from Ganoderma lucidum [DOI]
32. 32 Quaternary Structure, Substrate Selectivity and Inhibitor Design for SARS 3C-Like Proteinase [DOI]
33. 33 In silico target fishing and pharmacological profiling for the isoquinoline alkaloids of Macleaya cordata (Bo Luo Hui) [DOI]
34. 34 Identification of “Multiple Components‐Multiple Targets‐Multiple Pathways” Associated with Naoxintong Capsule in the Treatment of Heart Diseases Using UPLC/Q‐TOF‐MS and Network Pharmacology [DOI]
35. 35 Synthesis of Novel Test Compounds for Antiviral Chemotherapy of Severe Acute Respiratory Syndrome (SARS) [DOI]
36. 36 Network pharmacology-based prediction of the multi-target capabilities of the compounds in Taohong Siwu decoction, and their application in osteoarthritis [DOI]
37. 37 Prediction of Multi-Target Networks of Neuroprotective Compounds with Entropy Indices and Synthesis, Assay, and Theoretical Study of New Asymmetric 1,2-Rasagiline Carbamates [DOI]
38. 38 Exploring the anti-proliferative activity of Pelargonium sidoides DC with in silico target identification and network pharmacology [DOI]
39. 39 Tools for network pharmacology study: network visualization and network analysis [DOI]
40. 40 Drugs affecting plasma fibrinogen levels. Implications for new antithrombotic strategies [DOI]
41. 41 Drugs Affecting Thrombosis and Atherosclerosis [DOI]
42. 42 China Journal of Chinese Materia Medica [DOI]
43. 43 Encyclopedia of dietary supplements [DOI]
44. 44 A to Z of thermodynamics [DOI]
45. 45 [2019-nCoV: new challenges from coronavirus]. [DOI]

Cited by 18

Showing 8 of 18 known citations — external sources report more than can currently be individually listed.

Related research

• COVID 19 Disease Caused by Coronavirus 2 (SARS-CoV-2) (Severe Acute Respiratory Syndrome) — shares topic coverage
• Assessment of Anxiety in Healthcare Providers Working in ICU during COVID-19 Pandemics — shares topic coverage
• Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19 — shares topic coverage
• Elevated Levels of Lactate Dehydrogenase Predicts Poor Outcomes for Patients with COVID-19: A Review — shares topic coverage
• Addressing the Challenges of Containing Covid-19 Spread in a Rural, Poor Area in India: A Case Study — shares topic coverage